Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-02-12Clinical Trial Update: Symbicort in Chronic Obstruktive Pulmonary Disease
A completed clinical trial evaluating Symbicort (budesonide/formoterol) for chronic obstructive pulmonary disease.
-
FDA approval · 2008-02-05FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for XOPENEX HFA (levalbuterol tartrate) from Lupin Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2008-01-16Clinical Trial Update: Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) [Phase 2]
A Phase 2 feasibility study (FORTE) investigated retinoic acid as a treatment for emphysema; the trial has completed, with results not provi…
-
CLINICAL_TRIALS trial_result · 2008-01-08Clinical Trial Update: Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 1]
A Phase 1 study assessed the safety and tolerability of several inhaled doses of NVA237 in patients with chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS trial_result · 2008-01-08Clinical Trial Update: Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2 [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating methods of oxygen delivery and their effect on transcutaneous PaCO2 was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-12-31FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Nephron Pharmaceuticals Corporation)
The FDA approved Nephron Pharmaceuticals' original application for a generic ipratropium bromide and albuterol sulfate combination inhaler f…
-
FDA approval · 2007-12-31FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for a generic ipratropium bromide and albuterol sulfate inhalation product.
-
CLINICAL_TRIALS trial_result · 2007-12-11Clinical Trial Update: Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment [Phase 4]
Phase 4 clinical trial update from the University of Alberta describes outcomes of clinical activities performed by a rounding pharmacist in…
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: Phase 2 Study - Erdosteine in Patients With CB/COPD [Phase 2]
A completed Phase 2 trial evaluating erdosteine in chronic bronchitis and chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2007-11-21Clinical Trial Update: Change of Inspiratory Peak Flow in COPD [Phase 4]
Phase 4 clinical trial update on inspiratory peak flow in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: Cognitive Behavioral Therapy for Anxiety and Depression in COPD [Phase 2]
Phase 2 study evaluating cognitive behavioral therapy for anxiety and depressive symptoms in chronic obstructive pulmonary disease has compl…
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Regulatory T Cells in COPD
A completed ClinicalTrials.gov entry about a trial investigating regulatory T cells in chronic obstructive pulmonary disease, sponsored by G…
-
CLINICAL_TRIALS trial_result · 2007-11-05Clinical Trial Update: Use of Dexmedetomidine for Sedation During Flexible Bronchoscopy in Patients With COPD: A Descriptive Study [NA]
A completed descriptive study evaluating the use of dexmedetomidine for sedation during flexible bronchoscopy in patients with chronic obstr…
-
CLINICAL_TRIALS trial_result · 2007-11-02Clinical Trial Update: Effects of Temazepam in Patients With Chronic Pulmonary Obstructive Disease [Phase 3]
A Phase 3 clinical trial evaluating temazepam in patients with chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-02Clinical Trial Update: Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease [NA]
This document reports the completion of a clinical trial evaluating whether endorphins influence the perception of dyspnea in patients with …
-
FDA approval · 2007-10-31FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide/formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP. The ac…
-
FDA approval · 2007-10-26FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Budesonide and Formoterol Fumarate Dihydrate from AstraZeneca, updating the product’s labeli…
-
CLINICAL_TRIALS trial_result · 2007-10-12Clinical Trial Update: The Effects of a Home Exercise Video Programme for Patients With COPD [Phase 2]
This document provides a Phase 2 clinical trial update on a home exercise video programme for patients with Chronic Obstructive Pulmonary Di…
-
CLINICAL_TRIALS trial_result · 2007-09-06Clinical Trial Update: Effects of Salmeterol on Walking Capacity in Patients With COPD [Phase 4]
This update reports a completed Phase 4 trial evaluating the effect of salmeterol on walking capacity in patients with chronic obstructive p…
-
CLINICAL_TRIALS trial_result · 2007-08-14Clinical Trial Update: Noninvasive Positive Pressure Ventilation Using Helium:Oxygen Versus Air:Oxygen in Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients Exposed to Sulfur Mustard [Phase 3]
Phase 3 trial comparing helium-oxygen noninvasive ventilation versus air-oxygen in acute respiratory failure among COPD patients exposed to …
-
CLINICAL_TRIALS trial_result · 2007-08-14Clinical Trial Update: Internet-Based and Established Dyspnea Self-Management Programs in Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
A completed clinical trial evaluating internet-based and established dyspnea self-management programs for patients with chronic obstructive …
-
CLINICAL_TRIALS research · 2007-08-03Clinical Trial Update: Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung
A completed clinical trial from Tel-Aviv Sourasky Medical Center examining soluble factors and particulate matter in induced sputum and exha…
-
CLINICAL_TRIALS trial_result · 2007-07-23Clinical Trial Update: Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD [Phase 2]
Pfizer's Phase 2 trial of UK-500,001 for chronic obstructive pulmonary disease was terminated.
-
FDA approval · 2007-06-26FDA Approved: ALBUTEROL SULFATE — Original Application (Chartwell RX, LLC)
FDA approved a generic albuterol sulfate product under an Original Application for Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol [Phase 1, Phase 2]
This Phase 1/2 trial update examines indacaterol's effect on inspiratory capacity and lung function in patients with chronic obstructive pul…